Hena Patel

Hena Patel practices at The University of Chicago Medical Center in Chicago, Illinois.

Hena Patel's NPI, 1962840843, was assigned on June 12, 2013. Hena Patel holds Illinois license 036140248.

Hena Patel's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Hena Patel's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Hena Patel is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Hena Patel to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hena Patel practices. Vendor and product names are available with a free account.

Cardiovascular disease is Hena Patel's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Hena Patel is licensed in Illinois.

CMS data shows 1,355 Medicare services from Hena Patel across 17 procedure codes in 2024, for 1,148 Medicare patients. Medicare paid $84,846 for them.

CMS counts 1,148 Medicare patients who saw Hena Patel in 2024. The largest group is 65 to 74, with 480 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hena Patel's median patient age at 69, with 54% women.

In 2024, Hena Patel wrote 139 Medicare Part D claims for 23 patients. 94% of them were for generic drugs. CMS names the drug for 97 of them, across 5 drugs with 11 or more claims each, at $1,304 in total drug cost. In 2023, CMS named 76 claims across 5 drugs.

Hena Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Hena Patel as offering telehealth.

CMS Open Payments shows 50 general payments to Hena Patel from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. GE Healthcare paid the most, $3,795.